Pediatric and adolescent endocrinology
The DOI matches its Crossref record.
Abstract
Abstract Disclosure: A. Sharma: None. K. Ambulkar: None. M. Karlekar: None. S. Memon: None. V. Patil: None. N. Agarwal: None. V. Sarathi: None. A. Lila: None. S. Rege: None. H. Thakkar: None. G. Malhotra: None. R. Barnabas: None. N. Shah: None. T. Bandgar: None. Background: Data on pediatric/adolescent von Hippel-Lindau (VHL) disease is sparse, and comprehensive studies detailing the phenotype of all the associated neoplasms are lacking. Their current surveillance and management rely on expert opinion/extrapolation from adults, not individualized to the mutation type.Objective: To characterize the childhood/adolescent-onset VHL disease phenotype, compare it to adult-onset disease, and identify genotype-phenotype correlations.Methods: This was a retrospective review of children/adolescents (≤19 years) and adults (≥20 years) with a clinical (15%) or genetic (85%: 66% missense, and 19% truncating variants) diagnosis of VHL disease from a single endocrine center (2000-2024). Only neoplasms diagnosed until 19 years of age were included in the childhood/adolescent group and compared with the last follow-up of adults. The demographic, clinical data, genetics, anatomical/functional imaging, operative details, and histopathology (in operated patients) were noted for each VHL-associated neoplasm.Results: In 26 children/adolescents, by age 19 years, 81% (21/26) developed pheochromocytoma/paraganglioma (PPGL, of which 10% head and neck), 42% (10/24) central nervous system hemangioblastoma (CNS-HB), 31% each retinal RHB (5/16) and pancreatic neuroendocrine tumor (PNET, 8/26), and none endolymphatic sac tumor/renal cell carcinoma. At diagnosis, all those with PPGLs were symptomatic (median size 4.5 cm, 52 lesions). CNS-HBs showed female preponderance, a high disease burden (60% symptomatic, 50% synchronous in ≥2/3 components of the neuroaxis), and surgical requirement by age 19. Two pediatric patients needed surgery for a symptomatic PNET before the recommended surveillance initiation age (15 years). Two developed polycythemia on follow-up. Compared to adults (n=39), pediatric/adolescent PPGL patients had significantly higher baseline plasma free-normetanephrine (median 1099 vs. 2513 pg/mL), more bilateral (47% vs. 76%) and extra-adrenal (19% vs. 48%) disease by 19 years, and 8.3-fold higher operative-site recurrence over a similar follow-up duration (median 108 months in adults vs. 75 months in children/adolescents) independent of cortical-sparing surgery. CNS/RHB and PNET frequency and burden by 19 years resembled adults. Childhood/adolescent PPGLs occurred predominantly (16/17) and PNETs exclusively, with missense variants. Codon 167 missense variants were associated with synchronous bilateral pheochromocytomas.Conclusion: In pediatric/adolescent VHL disease, we report a severe phenotype, more extensive (PPGL) or comparable to adults, and the need for head and neck PGL and earlier PNET surveillance. The occurrence of PPGLs and PNETs almost exclusively in children and adolescents with missense VHL variants suggests the genotype may guide the pediatric surveillance strategy for these neoplasms. Presentation: Monday, July 14, 2025
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Androgen Receptor Defects: Historical, Clinical, and Molecular Perspectives*
QUIGLEY, C. A., BELLIS, A. D., MARSCHKE, K. B., EL-AWADY, M. K., WILSON, E. M., & FRENCH, F. S. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-3-271 · Cited by 1,447
Growth Hormone (GH) Insensitivity Due to Primary GH Receptor Deficiency
ROSENFELD, R. G., ROSENBLOOM, A. L., & GUEVARA-AGUIRRE, J. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-3-369 · Cited by 482
Dorn, L. D., Dahl, R. E., Woodward, H. R., & Biro, F. (2006) · Applied Developmental Science · doi:10.1207/s1532480xads1001_3 · Cited by 477
Gender dysphoria and gender change in chromosomal females with congenital adrenal hyperplasia
Dessens, A. B., Slijper, F. M. E., & Drop, S. L. S. (2005) · Archives of Sexual Behavior · doi:10.1007/s10508-005-4338-5 · Cited by 425
Transitioning From Pediatric to Adult Care
Weissberg-Benchell, J., Wolpert, H., & Anderson, B. J. (2007) · Diabetes Care · doi:10.2337/dc07-1249 · Cited by 268
Metadata
- Authors
- Lodeweyckx, M.
- Venue
- European Journal of Obstetrics & Gynecology and Reproductive Biology
- Publisher
- Elsevier BV
- Published
- 1983-01
- Volume
- 14
- Issue
- 4
- Pages
- 266-267
- ISSN
- 0028-2243 (ISSN-L)
- 0301-2115
- OpenAlex
- W2325479395
- Cited by
- 145
- References
- 0
- FWCI
- 8.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pediatric and adolescent endocrinology. https://app.cochat.ai/papers/10.1016/0028-2243(83)90276-9
- The paper
- Lodeweyckx, M. (1983). Pediatric and adolescent endocrinology. European Journal of Obstetrics & Gynecology and Reproductive Biology. https://doi.org/10.1016/0028-2243(83)90276-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.